Home > Boards > US Listed > Medical - Healthcare > Acasti Pharma, Inc (ACST)

why do you say that?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
[SMART MONEY]  Member Profile
Member Level 
Followed By 3,141
Posts 112,964
Boards Moderated 7
Alias Born 08/05/09
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/19/2019 8:01:44 AM
Acasti Pharma Schedules Fourth Quarter and Fiscal 2019 Conference Call GlobeNewswire Inc. - 6/19/2019 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/4/2019 9:16:44 AM
Acasti Pharma Announces TRILOGY 2 Trial Has Achieved its 100% Patient Randomization Target in Patients with Severe Hypertrigl... GlobeNewswire Inc. - 6/4/2019 9:15:00 AM
Acasti Issues Shares in Settlement of Claims with Former Chief Executive Officer GlobeNewswire Inc. - 5/23/2019 5:00:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/21/2019 7:32:31 AM
Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference GlobeNewswire Inc. - 5/21/2019 7:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/15/2019 7:57:19 AM
Acasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and Israel GlobeNewswire Inc. - 5/15/2019 7:55:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/10/2019 10:06:44 AM
Acasti Settles Claims with Former Chief Executive Officer GlobeNewswire Inc. - 5/10/2019 7:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/24/2019 8:36:27 AM
Acasti Pharma CEO to Present at the ThinkEquity Conference on May 2nd in New York City GlobeNewswire Inc. - 4/24/2019 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/15/2019 9:16:25 AM
Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in Patients with Severe Hypertriglyceridemia... GlobeNewswire Inc. - 4/15/2019 9:15:00 AM
Acasti Pharma Announces Publication of CaPre Bioavailability Study in Leading Peer-Reviewed Journal GlobeNewswire Inc. - 4/1/2019 9:20:53 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/26/2019 8:31:38 AM
Acasti Pharma to Present at the 2019 Spring Investor Summit in New York City on April 2nd GlobeNewswire Inc. - 3/26/2019 8:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/13/2019 8:31:53 AM
Acasti Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference on March 19th GlobeNewswire Inc. - 3/13/2019 8:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/21/2019 9:18:57 AM
Acasti Pharma Recognized in TSX Venture Exchange’s 2019 Venture 50 GlobeNewswire Inc. - 2/21/2019 9:15:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/14/2019 8:15:53 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/14/2019 8:07:40 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/14/2019 8:06:47 AM
[SMART MONEY] Member Level  Monday, 09/24/18 10:25:09 AM
Re: davidsson10 post# 435
Post # of 460 
why do you say that?

are they in the same drug sector?



Always consult an Investment Professional, my posts are my own
opinions, and not for investing decisions!
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist